Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 241.94 M239.81 M236.73 M— — Research & development ———— — Operating income 230.36 M225.04 M223.17 M— — Non-Operating Income, Total -3.49 M3.83 M1.04 M— — Interest expense, net of interest capitalized 46.23 M44.65 M45.01 M— — Non-Operating Income, excl. Interest Expenses -49.72 M-40.82 M-43.97 M— — Unusual income/expense ———— — Pretax income 180.64 M168.25 M179.2 M770.34 M 1.3 B Equity in earnings ———— — Taxes 40.83 M37.16 M39.88 M168.68 M 286.55 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 139.81 M131.09 M139.32 M601.66 M 1.01 B Discontinued operations ———— — Net income 139.81 M131.09 M139.32 M601.66 M 1.01 B Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 139.81 M131.09 M139.32 M601.66 M 1.01 B Basic earnings per share (Basic EPS) 4.163.844.11— — Diluted earnings per share (Diluted EPS) 4.133.814.0817.57 29.59 Average basic shares outstanding 33.61 M34.16 M33.92 M34.01 M — Diluted shares outstanding 33.82 M34.4 M34.15 M34.24 M — EBITDA 204.64 M205.59 M205.25 M— — EBIT 201.79 M204.35 M202.66 M— — Cost of revenue 686.08 M684.17 M687.15 M— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 2.86 M1.24 M2.59 M— —